| 专利名称 | ANTI-KIR3DL1 ANTIBODIES | ||
| 申请号 | US16484451 | 申请日 | |
| 公开（公告）号 | US20200031927A1 | 公开（公告）日 | |
| 申请（专利权）人 | Memorial Sloan Kettering Cancer Center; Eureka Therapeutics Inc | 发明人 | Katharine HSU; Nai Kong V Cheung; Su YAN; Yiyang XU; Jingyi XIANG; Cheng LIU |
| 专利来源 | 国家知识产权局 | 转化方式 | |
| 摘要 |
The disclosure provides antibody agents that bind to inhibitory human killer immunoglobulin-like receptors (KIRs). Particular antibody agents of the disclosure include antibody agents that bind to KIR3DL1 (also known as CD158e). Also provided are related nucleic acids, vectors, compositions and methods of using KIR-binding antibody agents of the present technology. |
||
主管部门：海南中小企业服务 | 建设单位：海南商业联合会
版权所有：海南商业联合会 | 备案号：粤ICP备13083911号（ICP加挂服务）@2017
